Multiparametric MRI fusion-guided prostate biopsy in biopsy naive patients: Preliminary results from 80 patients

Abstract

A P e e r -R e v i e w e d B i m o n t h l y J o u r n a l I S S N 2 1 4 9 -3 2 3 5 • E I S S N 2 1 4 9 -3 0 5 7 I n d e x e d i n P u b M e d , W e b o f S c i e n c e a n d S c o p u s İsa Burak Güney, et al., The role and effect of FDG-PET/CT on patient management and restaging of bladder carcinoma. Page: 423 A P e e r -R e v i e w e d B ı m o n t h l y J o u r n a l A P e e r -R e v i e w e d B ı m o n t h l y J o u r n a l A P e e r -R e v i e w e d B ı m o n t h l y J o u r n a l A P e e r -R e v i e w e d B ı m o n t h l y J o u r n a l AIMS AND SCOPE Turkish Journal of Urology (Turk J Urol) is the scientific, peer reviewed, open access publication of the Turkish Association of Urology. The journal is aThe aim of the Turkish Journal of Urology is to contribute to the literature by publishing scientifically high-quality research articles as well as reviews, editorials, letters to the editor and case reports.The journal's target audience includes, urology specialists, medical specialty fellows and other specialists and practitioners who are interested in the field of urology.The editorial and publication processes of the journal are shaped in accordance with the guidelines of the International

Single center results of magnetic resonance imaging ultrasound guided fusion prostate biopsy obtained patients

“…In a prospective study by Murphy et al involving biopsy-naïve 39 patients who underwent fusion biopsy, PI-RADS scores of detected lesions were found to be significantly higher than benign lesions (25). Sonmez et al reported higher rates of PCa detection in patients with PI-RADS-4 or 5 lesions than those with PI-RADS-3 lesions (26). In our study, in accordance with the literature, it was observed that detected cancer rates in PIRADS-4 and 5 lesions were higher than PI-RADS-3 lesions.…”

A Single-center Experience: Does MRI-guided Target Prostate Biopsy Meet Expectations?

“…MpMRI-guided FPB has been shown to provide successful outcomes in patients with a history of negative biopsy and has become a well-established biopsy technique [5-6]. Additionally, it has recently emerged as a successful technique in biopsy-naïve patients as well [7-9]. As expected, based on these data, the findings of the present study that evaluated both biopsy-naïve and previous negative biopsy patients indicated that TB had the lowest number of core and CB had the highest (p<0.001).…”

“…FPB is recommended primarily for repeat biopsy in patients with a clinical suspicion of PCa whose initial prostate biopsies were negative and for follow-up biopsy in PCa patients on active follow-up and for patients who have a clinical suspicion of recurrence after local minimally invasive treatment (e.g., radiotherapy or high-intensity focused ultrasound (HIFU)) [5-6]. Additionally, FPB has been recently shown to provide effective outcomes in biopsy-naïve patients [7-9].…”

“…MpMRI-targeted biopsy (TB), a part of fusion biopsy, was first introduced in the early 2010s, predominantly to investigate whether better outcomes can be obtained by performing a biopsy on target lesions with fewer cores [10-11]. In later years, however, combined prostate biopsy (CB) (SPB + TB), which adopted a higher number of cores and was shown to have higher cancer detection rates, became a popular technique [7,12-13].…”

A Prospective Study and Single Center Experience: Effectivity of Fusion Prostate Biopsy in Biopsy-Naïve Patients

“…In one of our previous studies, we prospectively evaluated our early results of 80 patients and we found that the FPB administered in CB could be a successful technique in biopsy-naïve patients [ 10 ]. In the present study, we aimed to evaluate clinical outcomes of another cohort of 400 biopsy-naïve patients with a PSA level of 2-10 ng/ml.…”